REGEN-COV (casirivimab/imdevimab) - Regeneron, Roche
bamlanivimab (LY-CoV555) - Eli Lilly, AbCellera, National Institute of Allergy and Infectious Diseases
Xevudy (sotrovimab) - GSK, National Institutes of Health, Vir Biotech, National Institute of Allergy and Infectious Diseases
http://www.ncbi.nlm.nih.gov/pubmed/36638398
 
Jan 14, 2023
 
Prev Next